If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSouth32 Limited Regulatory News (S32)

Share Price Information for South32 Limited (S32)

Share Price is delayed by 15 minutes
Get Live Data
201.00    -9.00 (-4.29%)
Bid:
201.00
Ask:
201.60
Spread: 0.60 (0.299%)
Market Cap: £9.00b
S32 Live PriceLast checked at - London Stock Exchange

Intraday South32 Limited Share Chart

Annual Report

8 Sep 2023 07:00

RNS Number : 8447L
South32 Limited
08 September 2023
 

South32 Limited

(Incorporated in Australia under the Corporations Act 2001 (Cth))

(ACN 093 732 597)

ASX / LSE / JSE Share Code: S32; ADR: SOUHY

ISIN: AU000000S320

8 September 2023

 

2023 ANNUAL REPORT

South32 Limited (ASX, JSE, LSE: S32; ADR: SOUHY) (South32) advises that the following documents in PDF format have today been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

2023 Annual Report

2023 Corporate Governance Statement

Appendix 4G: Key to Disclosures - Corporate Governance Council Principles & Recommendations

These documents may be accessed via South32's website at https://www.south32.net/investors/annual-reporting-suite or www.south32.net.

The 2023 Annual Report is available on the National Storage Mechanism in unedited full text will be uploaded in structured electronic format on 13 September 2023.

About us

South32 is a globally diversified mining and metals company. Our purpose is to make a difference by developing natural resources, improving people's lives now and for generations to come. We are trusted by our owners and partners to realise the potential of their resources. We produce commodities including bauxite, alumina, aluminium, copper, silver, lead, zinc, nickel, metallurgical coal and manganese from our operations in Australia, Southern Africa and South America. With a focus on growing our base metals exposure, we also have two development options in North America and several partnerships with junior explorers around the world.

 

Investor Relations

 

 

Ben BakerT +61 8 9324 9363M +61 403 763 086E Ben.Baker@south32.net

 

Media Relations

 

 

Jamie Macdonald T +61 8 9324 9000M +61 408 925 140E Jamie.Macdonald@south32.net

 

Miles Godfrey T +61 8 9324 9000M +61 415 325 906E Miles.Godfrey@south32.net

 

Further information on South32 can be found at www.south32.net.

Approved for release by Graham Kerr, Chief Executive OfficerJSE Sponsor: The Standard Bank of South Africa Limited8 September 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSEASNPELXDEEA
Date   Source Headline
27th Oct 202210:33 amRNS2022 Annual General Meeting Results
27th Oct 20227:58 amRNSDaily Share Buy Back Notice
27th Oct 20227:28 amRNS2022 AGM - Chair and CEO Addresses
26th Oct 20228:03 amRNSDaily Share Buy-Back Notice
24th Oct 20227:00 amRNSQuarterly Report - September 2022
21st Oct 20229:02 amRNSDaily Share Buy-Back Notice
20th Oct 20228:06 amRNSDaily Share Buy-Back Notice
19th Oct 20229:24 amRNSDaily Share Buy-Back Notice
13th Oct 20228:11 amRNSNotification of Securities
13th Oct 20227:56 amRNSDaily Share Buy-Back Notice
12th Oct 20227:47 amRNSDaily Share Buy-Back Notice
11th Oct 20229:04 amRNSDaily Share Buy-Back Notice
10th Oct 20228:31 amRNSDaily Share-Buy Back Notice
7th Oct 20228:03 amRNSDaily Share Buy-Back Notice
5th Oct 20228:25 amRNSDaily Share Buy-Back Notice
3rd Oct 20229:05 amRNSTotal Voting Rights
30th Sep 20229:05 amRNSDaily Share Buy-Back Notice
29th Sep 20228:57 amRNSDaily Share Buy-Back Notice
28th Sep 20228:28 amRNSDaily Share Buy-Back Notice
23rd Sep 20229:07 amRNSDaily Share Buy-Back Notice
21st Sep 202210:39 amRNSFinal and Special Dividend Currency Exchange Rates
21st Sep 202210:22 amRNSUpdate to Notification of Dividend
21st Sep 20228:36 amRNSNotice of AGM
20th Sep 20227:55 amRNSDaily Share Buy-Back Notice
19th Sep 20228:34 amRNSDaily Share Buy-Back Notice
16th Sep 20228:20 amRNSDaily Share Buy-Back Notice
14th Sep 20228:07 amRNSDaily Share Buy-Back Notice
13th Sep 20228:07 amRNSDaily Share Buy-Back Notice
12th Sep 20228:45 amRNSDaily Share Buy-Back Notice
9th Sep 202210:40 amRNSPayments to Governments Report 2022
9th Sep 20228:46 amRNSAnnual Report 2022
9th Sep 20228:27 amRNSDaily Share Buy-Back Notice
7th Sep 20228:55 amRNSDaily Share Buy-Back Notice
6th Sep 20228:08 amRNSDaily Share Buy-Back Notice
5th Sep 20228:59 amRNSDaily Share Buy-Back Notice
2nd Sep 20228:40 amRNSDaily Share Buy-Back Notice
2nd Sep 20228:27 amRNSDaily Share Buy-Back
31st Aug 20229:44 amRNSDaily Share Buy-Back Notice
30th Aug 20221:07 pmRNSNOTIFICATION OF SECURITIES
30th Aug 202210:06 amRNSDirector/PDMR Shareholding
25th Aug 20227:00 amRNSFY22 Full Year Results Presentation
25th Aug 20227:00 amRNSNotification of Dividend
25th Aug 20227:00 amRNSFinancial Results for Year Ending 30 June 2022
25th Aug 20227:00 amRNSChanges Relating to Buy-Back
23rd Aug 20227:08 amRNSDendrobium Next Domain Update
25th Jul 202212:22 pmRNSTR-1: notification of major holdings
25th Jul 20227:00 amRNSQuarterly Report June 2022
12th Jul 20229:34 amRNSNotification of Securities
12th Jul 20227:38 amRNSUS$200M in Value Unlocked From Royalty Sale
1st Jul 20229:07 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.